trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Lakshmi SV et al. Oxidative stress in coronary artery disease: epigenetic perspective. 2013 Mol. Cell. Biochem. pmid:23160801
Jackson MF et al. Genetic manipulation of myoblasts and a novel primary myosatellite cell culture system: comparing and optimizing approaches. 2013 FEBS J. pmid:23173931
Brown CO et al. Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. 2013 Leuk. Res. pmid:23537707
Humphreys KJ et al. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. 2013 Mol. Carcinog. pmid:22308110
Doñas C et al. Trichostatin A promotes the generation and suppressive functions of regulatory T cells. 2013 Clin. Dev. Immunol. pmid:23737814
Flight MH Behaviour: epigenetically bonded. 2013 Nat. Rev. Neurosci. pmid:23756635
Yamamura A et al. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer. 2013 Biochem. Biophys. Res. Commun. pmid:24134849
Liu Y et al. Expression loss and revivification of RhoB gene in ovary carcinoma carcinogenesis and development. 2013 PLoS ONE pmid:24223801
Hayakawa K et al. Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. 2013 J. Biol. Chem. pmid:23625921
Tang X et al. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer. 2012-2013 Cancer Biomark pmid:23321465
Hou W et al. Hypoxia-induced deacetylation is required for tetraploid differentiation in response to testicular ischemia-reperfusion (IR) injury. 2012 Nov-Dec J. Androl. pmid:22556385
Darlyuk-Saadon I et al. The bZIP repressor proteins, c-Jun dimerization protein 2 and activating transcription factor 3, recruit multiple HDAC members to the ATF3 promoter. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22989952
Guo X et al. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells. 2012 May-Jun Cell. Immunol. pmid:22776176
Mehdi O et al. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). 2012 Mar-Apr Pancreatology pmid:22487525
Rhodes LV et al. The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. 2012 Oncol. Rep. pmid:21971930
Hong X et al. Heparanase expression is associated with histone modifications in glioblastoma. 2012 Int. J. Oncol. pmid:22001963
Yang G et al. Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition. 2012 Cell Transplant pmid:21944777
Kadaja-Saarepuu L et al. Tumor suppressor p53 down-regulates expression of human leukocyte marker CD43 in non-hematopoietic tumor cells. 2012 Int. J. Oncol. pmid:21947346
Ekici M et al. Chromatin structure and expression of the AMPA receptor subunit Glur2 in human glioma cells: major regulatory role of REST and Sp1. 2012 J. Cell. Biochem. pmid:21948504
Rosborough BR et al. Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo. 2012 J. Leukoc. Biol. pmid:22028329
Ying H et al. Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaB. 2012 PLoS ONE pmid:23166597
Londhe P et al. CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells. 2012 Int. J. Cancer pmid:21989738
Tsuboi H et al. Epigenetic memory of DNAi associated with cytosine methylation and histone modification in fern. 2012 Plant Signal Behav pmid:22990449
Anh TD et al. The histone deacetylase inhibitor, Trichostatin A, induces G2/M phase arrest and apoptosis in YD-10B oral squamous carcinoma cells. 2012 Oncol. Rep. pmid:21993600
Gillespie J et al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. 2012 Arthritis Rheum. pmid:21952924
Maroni P et al. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors. 2012 Biochem. Biophys. Res. Commun. pmid:23085045
He D et al. Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma. 2012 Eur. J. Cancer Prev. pmid:22273848
Hosoya T et al. Trichostatin analogues JBIR-109, JBIR-110, and JBIR-111 from the marine sponge-derived Streptomyces sp. RM72. 2012 J. Nat. Prod. pmid:22276693
Baud MG et al. Defining the mechanism of action and enzymatic selectivity of psammaplin A against its epigenetic targets. 2012 J. Med. Chem. pmid:22280363
Heller G et al. Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers. 2012 Clin. Cancer Res. pmid:22282464
Hirata Y et al. Anti-tumor activity of new orally bioavailable 2-amino-5-(thiophen-2-yl)benzamide-series histone deacetylase inhibitors, possessing an aqueous soluble functional group as a surface recognition domain. 2012 Bioorg. Med. Chem. Lett. pmid:22321215
Sawai K et al. Epigenetic status and full-term development of bovine cloned embryos treated with trichostatin A. 2012 J. Reprod. Dev. pmid:22322145
Banerjee A et al. Trichostatin A abrogates airway constriction, but not inflammation, in murine and human asthma models. 2012 Am. J. Respir. Cell Mol. Biol. pmid:22298527
Kerr JB et al. The primordial follicle reserve is not renewed after chemical or γ-irradiation mediated depletion. 2012 Reproduction pmid:22301887
Li H et al. Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. 2012 Diabetes pmid:22338096
Duncan HF et al. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. 2012 J Endod pmid:22341071
Kohda T et al. Gene expression profile normalization in cloned mice by trichostatin A treatment. 2012 Cell Reprogram pmid:22257163
Drzewiecka H and Jagodzinski PP Trichostatin A reduced phospholipase C gamma-1 transcript and protein contents in MCF-7 breast cancer cells. 2012 Biomed. Pharmacother. pmid:22257695
Shah S et al. Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. 2012 Cancer Res. pmid:22258452
Sadoul K et al. HDAC6 controls the kinetics of platelet activation. 2012 Blood pmid:22955928
de Souza CF et al. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. 2012 PLoS ONE pmid:22984562
Otsuji TG et al. Dynamic link between histone H3 acetylation and an increase in the functional characteristics of human ESC/iPSC-derived cardiomyocytes. 2012 PLoS ONE pmid:22984602
Ma P et al. Compensatory functions of histone deacetylase 1 (HDAC1) and HDAC2 regulate transcription and apoptosis during mouse oocyte development. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:22223663
Szablowska-Gadomska I et al. Treatment with small molecules is an important milestone towards the induction of pluripotency in neural stem cells derived from human cord blood. 2012 Acta Neurobiol Exp (Wars) pmid:23377265
Wang B et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. 2012 Free Radic. Biol. Med. pmid:22226832
Liu H et al. Inhibition of class II histone deacetylase blocks proliferation and promotes neuronal differentiation of the embryonic rat neural progenitor cells. 2012 Acta Neurobiol Exp (Wars) pmid:23377267
Barrasa JI et al. Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells. 2012 Biochim. Biophys. Acta pmid:22227581
Becker JR et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. 2012 Cardiovasc. Res. pmid:22198505
Hsu YF et al. Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells. 2012 Biochim. Biophys. Acta pmid:22155142
Bebenek IG et al. CYP2S1 is negatively regulated by corticosteroids in human cell lines. 2012 Toxicol. Lett. pmid:22155357
Sakuma Y et al. WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors. 2012 Lab. Invest. pmid:22157722
Schor IE et al. Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. 2012 PLoS ONE pmid:23152763
Chang J et al. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide. 2012 Br. J. Cancer pmid:22158273
Calfa G et al. HDAC activity is required for BDNF to increase quantal neurotransmitter release and dendritic spine density in CA1 pyramidal neurons. 2012 Hippocampus pmid:22161912
Yao J et al. ERK inhibition enhances TSA-induced gastric cancer cell apoptosis via NF-κB-dependent and Notch-independent mechanism. 2012 Life Sci. pmid:22781708
Cheng DD et al. Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. 2012 Asian Pac. J. Cancer Prev. pmid:22799338
Mostovich LA et al. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer. 2012 Epigenetics pmid:22805760
Kadowaki M et al. DNA methylation-mediated silencing of nonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) in glioma cell lines. 2012 Int. J. Cancer pmid:21437897
Zou Y et al. Effect of phenylhexyl isothiocyanate on aberrant histone H3 methylation in primary human acute leukemia. 2012 J Hematol Oncol pmid:22747680
Scholl C et al. Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain. 2012 BMC Genomics pmid:22748179
Soleymani Fard S et al. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6). 2012 Prostaglandins Leukot. Essent. Fatty Acids pmid:22749740
Brose RD et al. Activation of the stress proteome as a mechanism for small molecule therapeutics. 2012 Hum. Mol. Genet. pmid:22752410
Jasek E et al. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. 2012 Anticancer Res. pmid:22753739
Gan L et al. Histone deacetylases regulate gonadotropin-releasing hormone I gene expression via modulating Otx2-driven transcriptional activity. 2012 PLoS ONE pmid:22761896
Cogdill AP et al. Targeting the MAGE A3 antigen in pancreatic cancer. 2012 Surgery pmid:22770803
Tu Z et al. The enhanced antiproliferative response to combined treatment of trichostatin A with raloxifene in MCF-7 breast cancer cells and its relevance to estrogen receptor β expression. 2012 Mol. Cell. Biochem. pmid:22476901
Halsall J et al. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. 2012 PLoS ONE pmid:22479401
Yoshida A et al. Aberrant spikelet and panicle1, encoding a TOPLESS-related transcriptional co-repressor, is involved in the regulation of meristem fate in rice. 2012 Plant J. pmid:22136599
Shen T et al. Upregulation of Polo-like kinase 2 gene expression by GATA-1 acetylation in human osteosarcoma MG-63 cells. 2012 Int. J. Biochem. Cell Biol. pmid:22138223
Rossi LE et al. Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression. 2012 J. Leukoc. Biol. pmid:22124136
Jung N et al. Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma. 2012 J. Korean Med. Sci. pmid:22690089
Landreville S et al. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. 2012 Clin. Cancer Res. pmid:22038994
Nunes MJ et al. Okadaic acid inhibits the trichostatin A-mediated increase of human CYP46A1 neuronal expression in a ERK1/2-Sp3-dependent pathway. 2012 J. Lipid Res. pmid:22693257
Kim Y et al. Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein. 2012 J. Biol. Chem. pmid:22679019
Royce SG et al. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. 2012 Arch. Immunol. Ther. Exp. (Warsz.) pmid:22684086
Zhang YW et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation. 2012 PLoS ONE pmid:22701735
Mitchell MD et al. Epigenetic regulation of cytokine production in human amnion and villous placenta. 2012 Mediators Inflamm. pmid:22665947
Buurman R et al. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. 2012 Gastroenterology pmid:22641068
Orlova DY et al. Arrangement of nuclear structures is not transmitted through mitosis but is identical in sister cells. 2012 J. Cell. Biochem. pmid:22644811
Glait-Santar C et al. Expression pattern of SVEP1 alternatively-spliced forms. 2012 Gene pmid:22659106
Park J et al. ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. 2012 Biochem. Biophys. Res. Commun. pmid:22580278
Yin Z et al. Position effect variegation and epigenetic modification of a transgene in a pig model. 2012 Genet. Mol. Res. pmid:22370938
Halldórsdóttir AM et al. Mantle cell lymphoma displays a homogenous methylation profile: a comparative analysis with chronic lymphocytic leukemia. 2012 Am. J. Hematol. pmid:22374828
Schnichels S et al. Trichostatin A induces cell death at the concentration recommended to differentiate the RGC-5 cell line. 2012 Neurochem. Int. pmid:22391323
Fan LX et al. Inhibition of histone deacetylases targets the transcription regulator Id2 to attenuate cystic epithelial cell proliferation. 2012 Kidney Int. pmid:21900881
Zhu L et al. Hyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal rats. 2012 Pediatr. Pulmonol. pmid:21905265
Karolczak-Bayatti M et al. Expression of the GTP-binding protein Gαs in human myometrial cells is regulated by ubiquitination and protein degradation: involvement of proteasomal inhibition by trichostatin A. 2012 Reprod Sci pmid:22875848
Pufahl L et al. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3. 2012 J. Cell. Mol. Med. pmid:21883892
Balaguer TM et al. Dual regulation of P-glycoprotein expression by trichostatin A in cancer cell lines. 2012 BMC Mol. Biol. pmid:22846052
Li L et al. Regulation of histone acetylation by NDRG2 in glioma cells. 2012 J. Neurooncol. pmid:21912936
Yang F et al. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte. 2012 Int. J. Dev. Biol. pmid:23417411
Li L et al. Use of mouse hematopoietic stem and progenitor cells to treat acute kidney injury. 2012 Am. J. Physiol. Renal Physiol. pmid:21937606
Dehnugara T et al. An in vitro, short-term culture method for mammalian haploid round spermatids amenable for molecular manipulation. 2012 Mol. Reprod. Dev. pmid:21953649
Zhang QC et al. Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. 2012 Asian Pac. J. Cancer Prev. pmid:22994780
Xie BT et al. [Telomere lengthening by trichostatin A treatment in cloned pigs]. 2012 Yi Chuan pmid:23262106
He M and Guo Q [Cerebral protection of Trichostatin A preconditioning in rats with middle cerebral artery occlusion and the relationship between Trichostatin A and IL-1β]. 2012 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:22561570
Catalano MG et al. Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells. 2012 J. Clin. Endocrinol. Metab. pmid:22563106
Yu L et al. Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. 2012 Arch. Med. Res. pmid:22564421
Bobkov DE et al. [Isolation of tropomyosin particles from the cytosol of cultured cells and their protein composition analysis]. 2012 Tsitologiia pmid:22567898
Li Q and Chen H Silencing of Wnt5a during colon cancer metastasis involves histone modifications. 2012 Epigenetics pmid:22522911